Skip to Main Content Go to Sitemap

News & Stories

Read the latest news and stories in the SickKids newsroom. Looking to interview someone? Connect with our media team.

A child holding a plastic model of a liver

September 22, 2022

Landmark SickKids-led study offers new understanding of outcomes for children and youth with Alagille syndrome

In the largest study of its kind, SickKids researchers have described the natural history of Alagille syndrome, providing a more complete picture of how the liver disease progresses in childhood.

A 3D-rendered image of an infant's side profile. The infant's brain is highlighted in blue.

September 21, 2022

Study pinpoints origin of paediatric brain tumour and shows it may be preventable

An international research team uncovered the first indication that a type of medulloblastoma may be preventable by identifying how and where these tumours develop during human fetal brain development.

Go to article

September 16, 2022

Choosing Wisely: SickKids study leads to improved process for diagnosis and management of urinary tract infections (UTIs) in children

Research shows the implementation of a standardized approach to UTI diagnosis and follow-up reduced misdiagnosis and antibiotic use.

September 8, 2022

SickKids clinicians and researchers receive prestigious national honours

Five SickKids clinicians and researchers receive highly prestigious academic honours for their significant contributions to Canadian health sciences and paediatric medicine.

August 23, 2022

Hospitalizations for unintentional cannabis poisonings among Canadian children surged after legalization

Unique study from SickKids and The Ottawa Hospital found hospitalizations increased more in jurisdictions where the sale of cannabis edibles was allowed.

Young child sits on adult's lap. Adult is wearing a hair net. Another adult stands behind them.

August 15, 2022

Single-patient gene therapy clinical trial at SickKids carves a path for Precision Child Health

A SickKids team of doctors and researchers conducted a gene therapy clinical trial for a child with SPG50, one of the first examples of individualized genetic medicine.

Collage of the Research Institute trainees, featuring Kimberly Gauthier, Nifemi Adeoye, Kristine Keon, and Clare Burn Aschner

July 25, 2022

From undergrads to postdocs, meet our trainees in the SickKids Research Institute

The Research Institute is home to trainees who work alongside renowned scientists and researchers who are making invaluable contributions to the science being conducted at SickKids.

Child lays on bed of CT machine.

July 18, 2022

Choosing Wisely: Research shows low-risk injuries can safely forego abdominal CT imaging

With the typical rise in child and youth injuries from outdoor activities expected this summer, new research is helping to guide clinicians when CT imaging is needed most to help avoid unnecessary testing.

Six staff headshots grouped together in one image.

June 6, 2022

Six SickKids researchers among latest new and renewed Canada Research Chairs

Six scientists at SickKids Research Institute were awarded new or renewed Tier 1 and Tier 2 Canada Research Chairs through the University of Toronto.

SickKids Innovation Showcase

May 13, 2022

Innovation Showcase returns to highlight SickKids technologies and innovators

Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact.

May 12, 2022

Probe of DNA repeats reveals genetic link to schizophrenia

A SickKids-CAMH study shows long repeated DNA sequences found in the genome may contribute to how the complex psychiatric disorder arises.

Go to article

May 5, 2022

Nutrition International and SickKids research team to develop new data collection tools to identify threats to health and nutrition in emergency situations

SickKids and Nutrition International are joining forces to help identify data gaps and address the threats to health and nutrition information in low and middle-income countries.

Follow us on Twitter

Back to Top